Bharat Parenterals share news, announcements and annual reports
NSE: BPLPHARMABSE: 541096Pharmaceuticals & BiotechnologySmall Cap
Bharat Parenterals Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 2018
Last close ₹2,029.90up ₹117.30 (6.13%)BSE ₹2,026.65
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,912.60.
30 Oct: open ₹2,277.90, high ₹2,295.10, low ₹1,955.00
52-week range of BSE trades to 30 Oct 2026
₹880.25Low, 30 Mar 2026₹2,292.15High, 30 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,399 Cr1,597th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 1,124.69
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.21
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.05%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 0.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −0.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.50
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,61,73927.6% delivered
Bharat Parenterals board meetings
102 filed, newest first. Page 2 of 3.
Feb 2023
Nov 2022
12 Nov · Board meeting
7 Nov · Board meeting
Meeting on 12 Nov 2022: quarterly results
Aug 2022
29 Aug · Board meeting
Meeting on 29 Aug 2022: increase in authorised capital and annual general meeting2 Aug · Board meeting
Meeting on 10 Aug 2022: quarterly results
May 2022
16 May · Board meeting
Meeting on 28 May 2022: audited results
Feb 2022
9 Feb · Board meeting
Jan 2022
31 Jan · Board meeting
Meeting on 9 Feb 2022: quarterly results
Oct 2021
30 Oct · Board meeting
22 Oct · Board meeting
Meeting on 30 Oct 2021: quarterly results
Aug 2021
11 Aug · Board meeting
3 Aug · Board meeting
Meeting on 11 Aug 2021: quarterly results
May 2021
27 May · Board meeting
Meeting on 5 Jun 2021: audited results
Feb 2021
4 Feb · Board meeting
Meeting on 11 Feb 2021: quarterly results
Nov 2020
4 Nov · Board meeting
Meeting on 12 Nov 2020: quarterly results
Aug 2020
31 Aug · Board meeting
Meeting on 31 Aug 2020: employees stock option plan13 Aug · Board meeting
Meeting on 20 Aug 2020: quarterly results
Jun 2020
17 Jun · Board meeting
Meeting on 20 Jun 2020: audited results and quarterly results
Jan 2020
31 Jan · Board meeting
Meeting on 8 Feb 2020: quarterly results
Nov 2019
14 Nov · Board meeting
8 Nov · Board meeting
Meeting on 14 Nov 2019: quarterly results
Aug 2019
14 Aug · Board meeting
8 Aug · Board meeting
Meeting on 14 Aug 2019: quarterly results
May 2019
23 May · Board meeting
Meeting on 29 May 2019: audited results
Feb 2019
1 Feb · Board meeting
Meeting on 8 Feb 2019: quarterly results
Nov 2018
Aug 2018